Digest Network Come funziona
Network
/
Società
He
Non verificato

Healx

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteTecnica

6 comunicati stampa

Guarda tutti i comunicati
23/09/2025
Mercato del lavoro
Software
Scienza
Farmaceutica
Oncologia
Information Technology
Tecnica
Medicina - Varie
Biotecnologia
Salute
Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences
Fonte
Healx
Emittente
Business Wire
1.00
0
01/07/2025
Salute
Tecnica
Farmaceutica
Biotecnologia
Mercato del lavoro
Industria
Healx and SCI Ventures Join Forces to Uncover Cures for Paralysis with AI-Driven Drug Discovery
Fonte
Healx
Emittente
Business Wire
1.00
0
24/02/2025
Industria
Biotecnologia
Tecnica
Igiene alimentare
Salute
Farmaceutica
Oncologia
Scienza
Medicina - Varie
Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of Neurofibromatosis Type 1
Fonte
Healx
Emittente
Business Wire
1.00
0
03/12/2024
Mercato del lavoro
Tecnica
Scienza
Igiene alimentare
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Jonathan Milner, Ph.D., Appointed as Non-Executive Chairman of Healx
Fonte
Healx
Emittente
Business Wire
1.00
0
13/11/2024
Igiene alimentare
Information Technology
Sanità
Tecnica
Farmaceutica
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Tecnologie Varie
Biotecnologia
Scienza
Software
Salute
Mercato del lavoro
Industria
Healx announces agreement with Sanofi to seek new rare disease indications for compound using AI drug discovery platform
Fonte
Healx
Emittente
Business Wire
1.00
0
01/08/2024
Salute
Igiene alimentare
Tecnica
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Healx Announces $47 million Series C Financing and FDA Clearance of Phase 2 IND for Neurofibromatosis Type 1 Trial
Fonte
Healx
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0